ERCC4 and familial pancreatic carcinoma: Of the 8 individuals which possessed the heterozygous alleles and displayed elevated DNA damage, 6 were pancreatic cancer cases and 2 were healthy related control subjects (Table 6), suggesting that the increased DNA damage observed in the ERCC4 R415Q heterozygotes contributes to development of pancreatic cancer.